Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Wellcome Trust
Grant: 207511/Z/17/Z
Wellcome Trust
Grant: 214191/Z/18/Z
British Heart Foundation
Grant: AA/18/6/34223
British Heart Foundation
Grant: FS/19/35/34374
National Institute for Health Research (NIHR)
Grant: NIHR134607
Wellcome Trust
Grant: 214191
Harnessing tissue-resident CD8 T cells to manipulate hepatic immunity
UK Research and Innovation
Grant: MR/N007727/1
Tuning the immune response in tuberculosis
Wellcome Trust
Grant: 207511
Human Immune Response Variation in Tuberulosis
UK Research and Innovation
Grant: MR/S019553/1
'SPIICA' - the Sao Paulo-Imperial College Immune Correlates in Arbovirus Infection Network
European Commission
Grant: 860325
anti-Bacterial Innovative Vaccine Training Network.
UK Research and Innovation
Grant: MR/R02622X/1
Immunological tools for a seroprevalence and immune status map of Burkholderia pseudomallei and thailandensis in Vietnam
UK Research and Innovation
Grant: 10008614
T Cell Responder
UK Research and Innovation
Grant: MR/W020610/1
The Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.
UK Research and Innovation
Grant: MR/V036939/1
'REBRACOVID' - multicentre cohort study of the natural history and immunology of COVID-19 in Brazil
Fields of Study
Keywords